Wanwisa Waiyaput

No ORCID on file · 15 papers in corpus · active 2017-2022

Study types

  • article 15

Condition tags

  • endometriosis 9
  • adenomyosis 6
  • mesh:D004715 3
  • infertility 1
  • endometrioma 1
article 2022
International journal of fertility & sterility ·doi:10.22074/ijfs.2021.523075.1074

BACKGROUND: The differential diagnosis between uterine fibroid and adenomyosis is sometimes difficult; a precise diagnosis is required in women with infertility because of the different choice of treatments. Ultrasound elastography (UE) is …

article 2022
International journal of fertility & sterility ·doi:10.22074/ijfs.2021.527520.1104

Background: Dysregulation of the immune response contribute to a significant role in endometriosis. This research examined macrophages and natural killer (NK) cells numbers in endometriotic lesions and their association with the different l…

article 2022
PloS one ·doi:10.1371/journal.pone.0263283

Immune dysregulation can involve invasion and survival of endometrial glands inside the myometrium of the adenomyosis. There is limited available data concerning alterations of the bacterial microbiome in the reproductive tract of adenomyos…

article 2022
·doi:10.60692/y26mn-0mx81

Immune dysregulation can involve invasion and survival of endometrial glands inside the myometrium of the adenomyosis. There is limited available data concerning alterations of the bacterial microbiome in the reproductive tract of adenomyos…

article 2022
·doi:10.60692/tb295-5fk08

Immune dysregulation can involve invasion and survival of endometrial glands inside the myometrium of the adenomyosis. There is limited available data concerning alterations of the bacterial microbiome in the reproductive tract of adenomyos…

article 2021
·doi:10.60692/v92xh-f3e74

Abstract Background Dysregulation of immune response is associated with development of endometriosis. The study aim was to evaluate effect of combined oral contraceptive pills (COCs) consisting of ethinyl estradiol (EE) and desogestrel on t…

article 2021
·doi:10.60692/tny73-a4a66

Abstract Background Dysregulation of immune response is associated with development of endometriosis. The study aim was to evaluate effect of combined oral contraceptive pills (COCs) consisting of ethinyl estradiol (EE) and desogestrel on t…

article 2021
Journal of ovarian research ·doi:10.1186/s13048-021-00819-8

BACKGROUND: Dysregulation of immune response is associated with development of endometriosis. The study aim was to evaluate effect of combined oral contraceptive pills (COCs) consisting of ethinyl estradiol (EE) and desogestrel on the expre…

article 2021
Journal of family & reproductive health ·doi:10.18502/jfrh.v15i1.6077

Objective: Since endometriosis is an estrogen-dependent disease; therefore, combined oral contraceptives (COCs) may not be the best choice for the treatment of endometriosis. The objective of the present study was to investigate the effects…

article 2021
BioMed research international ·doi:10.1155/2021/5519538

Background . Autophagy is likely altered in patients with endometriosis. Ovarian steroid hormones seem to affect this changing of the autophagic process. Objective . To study the effect of combined oral contraceptive (COC) pills on the expr…

article 2021
·doi:10.1177/22840265211046750

Introduction: Both autophagy and apoptosis play a role in the cyclic remodeling of the endometrium. The abnormal regulation of genes and signaling pathways in the eutopic endometrium plays a role in the abnormal migration and implantation i…

article 2018
International journal of fertility & sterility ·doi:10.22074/ijfs.2018.5137

BACKGROUND: Progestin has been used for symptomatic treatment of adenomyosis, although its effect on the immune system has not been studied. The aim of this study was to investigate the changes of macrophage and natural killer (NK) cell inf…

article 2017
BMC women's health ·doi:10.1186/s12905-017-0446-3

Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattract…

article 2017
·doi:10.60692/012f2-g2169

Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattract…

article 2017
·doi:10.60692/nm0rb-15t96

Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattract…